The arc of discovery is moving abroad. While markets crashed in the United States and Europe, creditor countries like China focused deeply on investing in growing their crop of trained scientists and engineers, attracting research and development firms, and becoming the new hotbed of life sciences innovation. According to Tomasz Mroczkowski, Kogod international business professor, the life sciences industrial complex — the amalgam of pharma, biotech, health care, and computational sciences firms that will dominate the twenty-first century business landscape — is shifting to nations like China, India, and South Korea.
Mroczkowski sees this is as a good thing.
To read the full, original article click on this link: When Innovation Goes Global | American University Washington DC
